SLAMF7 and acute lymphoblastic leukemia: A similar trend was observed in 2B4 (MFIR = 2.07), CS1 (MFIR = 2.39) and NKp46 (MFIR = 2.04) expression on T cells of ALL subjects after induction chemotherapy (day 29) treatment, where expression demonstrated a decrease upon comparison to that of healthy donors of 3.48 (p = 0.0171), 3.89 (p = 0.0111) and 3.16 (p = 0.0473), respectively (Figure 4b–d).